195 related articles for article (PubMed ID: 22512667)
21. Improvement of an in vitro stem cell assay for developmental toxicity: the use of molecular endpoints in the embryonic stem cell test.
Seiler A; Visan A; Buesen R; Genschow E; Spielmann H
Reprod Toxicol; 2004; 18(2):231-40. PubMed ID: 15019721
[TBL] [Abstract][Full Text] [Related]
22. Validation of the embryonic stem cell test in the international ECVAM validation study on three in vitro embryotoxicity tests.
Genschow E; Spielmann H; Scholz G; Pohl I; Seiler A; Clemann N; Bremer S; Becker K
Altern Lab Anim; 2004 Sep; 32(3):209-44. PubMed ID: 15588166
[TBL] [Abstract][Full Text] [Related]
23. Prediction of in vivo embryotoxic effect levels with a combination of in vitro studies and PBPK modelling.
Verwei M; van Burgsteden JA; Krul CA; van de Sandt JJ; Freidig AP
Toxicol Lett; 2006 Aug; 165(1):79-87. PubMed ID: 16517103
[TBL] [Abstract][Full Text] [Related]
24. Development of a screening assay to identify teratogenic and embryotoxic chemicals using the zebrafish embryo.
Selderslaghs IW; Van Rompay AR; De Coen W; Witters HE
Reprod Toxicol; 2009 Nov; 28(3):308-20. PubMed ID: 19447169
[TBL] [Abstract][Full Text] [Related]
25. Relative developmental toxicity of glycol ether alkoxy acid metabolites in the embryonic stem cell test as compared with the in vivo potency of their parent compounds.
de Jong E; Louisse J; Verwei M; Blaauboer BJ; van de Sandt JJ; Woutersen RA; Rietjens IM; Piersma AH
Toxicol Sci; 2009 Jul; 110(1):117-24. PubMed ID: 19401353
[TBL] [Abstract][Full Text] [Related]
26. [Embryonic stem cell test in screening of medicine and other chemicals].
Zhao Q; Xu J
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2005 Feb; 22(1):181-4. PubMed ID: 15762145
[TBL] [Abstract][Full Text] [Related]
27. Disentangling cellular proliferation and differentiation in the embryonic stem cell test, and its impact on the experimental protocol.
van Dartel DA; Zeijen NJ; de la Fonteyne LJ; van Schooten FJ; Piersma AH
Reprod Toxicol; 2009 Sep; 28(2):254-61. PubMed ID: 19442486
[TBL] [Abstract][Full Text] [Related]
28. Unexpected common mechanistic pathways for embryotoxicity of warfarin and lovastatin.
Groebe K; Hayess K; Klemm-Manns M; Schwall G; Wozny W; Steemans M; Peters AK; Sastri C; Jaeckel P; Stegmann W; Zengerling H; Schöpf R; Poznanovic S; Stummann TC; Seiler A; Spielmann H; Schrattenholz A
Reprod Toxicol; 2010 Aug; 30(1):121-30. PubMed ID: 20493250
[TBL] [Abstract][Full Text] [Related]
29. [Improving the embryonic stem cell test (EST) by establishing molecular endpoints of tissue specific development using murine embryonic stem cells (D3 cells)].
Seiler A; Visan A; Pohl I; Genschow E; Buesen R; Spielmann H
ALTEX; 2002; 19 Suppl 1():55-63. PubMed ID: 12096331
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the mouse Embryonic Stem cell Test, the rat Whole Embryo Culture and the Zebrafish Embryotoxicity Test as alternative methods for developmental toxicity testing of six 1,2,4-triazoles.
de Jong E; Barenys M; Hermsen SA; Verhoef A; Ossendorp BC; Bessems JG; Piersma AH
Toxicol Appl Pharmacol; 2011 Jun; 253(2):103-11. PubMed ID: 21443896
[TBL] [Abstract][Full Text] [Related]
31. Selection of test chemicals for the ECVAM international validation study on in vitro embryotoxicity tests. European Centre for the Validation of Alternative Methods.
Brown NA
Altern Lab Anim; 2002; 30(2):177-98. PubMed ID: 11971754
[TBL] [Abstract][Full Text] [Related]
32. The teratology testing of cosmetics.
Spézia F; Barrow PC
Methods Mol Biol; 2013; 947():91-4. PubMed ID: 23138898
[TBL] [Abstract][Full Text] [Related]
33. Embryotoxicity of cobalt ferrite and gold nanoparticles: a first in vitro approach.
Di Guglielmo C; López DR; De Lapuente J; Mallafre JM; Suàrez MB
Reprod Toxicol; 2010 Sep; 30(2):271-6. PubMed ID: 20566333
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of in vitro embryotoxicity tests for Chinese herbal medicines.
Li L; Yin Tang L; Liang B; Wang R; Sun Q; Bik San Lau C; Chung Leung P; Fritsche E; Liebsch M; Seiler Wulczyn AEM; Spielmann H; Wang CC
Reprod Toxicol; 2019 Oct; 89():45-53. PubMed ID: 31228572
[TBL] [Abstract][Full Text] [Related]
35. Use of two validated in vitro tests to assess the embryotoxic potential of mycophenolic acid.
Eckardt K; Stahlmann R
Arch Toxicol; 2010 Jan; 84(1):37-43. PubMed ID: 19856175
[TBL] [Abstract][Full Text] [Related]
36. Validation successes: chemicals.
Spielmann H; Liebsch M
Altern Lab Anim; 2002 Dec; 30 Suppl 2():33-40. PubMed ID: 12513649
[TBL] [Abstract][Full Text] [Related]
37. Potency ranking of valproic acid analogues as to inhibition of cardiac differentiation of embryonic stem cells in comparison to their in vivo embryotoxicity.
de Jong E; Doedée AM; Reis-Fernandes MA; Nau H; Piersma AH
Reprod Toxicol; 2011 May; 31(4):375-82. PubMed ID: 21115111
[TBL] [Abstract][Full Text] [Related]
38. Validation of alternative methods for developmental toxicity testing.
Piersma AH
Toxicol Lett; 2004 Apr; 149(1-3):147-53. PubMed ID: 15093260
[TBL] [Abstract][Full Text] [Related]
39. Early gene expression changes during embryonic stem cell differentiation into cardiomyocytes and their modulation by monobutyl phthalate.
van Dartel DA; Pennings JL; Hendriksen PJ; van Schooten FJ; Piersma AH
Reprod Toxicol; 2009 Apr; 27(2):93-102. PubMed ID: 19162170
[TBL] [Abstract][Full Text] [Related]
40. Embryotoxicity hazard assessment of cadmium and arsenic compounds using embryonic stem cells.
Stummann TC; Hareng L; Bremer S
Toxicology; 2008 Oct; 252(1-3):118-22. PubMed ID: 18775467
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
